THE CLINICAL COURSE AND TREATMENT OF FUNGAL INFECTIONS IN THE EARLY PERIOD AFTER KIDNEY TRANSPLANTATION


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Acesso é pago ou somente para assinantes

Resumo

The article discusses the critical issues of clinical manifestations and treatment of fungal infections in patients after kidney transplantation. In fungal infection, which is usually detected in the composition of microbial associations, lungs are more often affected. In this case, mortality reaches 60%. Affecting the renal transplant by Candida spp. or Aspergillus spp. can lead to the loss of function of transplanted kidneys. At the current stage, lipid formulations of amphotericin B are drugs of choice for antimycotic therapy in posttransplant period. Nephrotoxic effect of amphotericin B is reversible and does not represent a serious threat to the function of the transplantate. Administration of lipid formulations of amphotericin B is the most justified, since it does not affect the concentration of immunosuppressive drugs in the blood serum of patients after transplantation.

Texto integral

Acesso é fechado

Bibliografia

  1. Denning D.W., Evans E.G., Kibbler C.C. Guidelines for the investigation of invasive fungal infections in haematological malignancy and solid organ transplantation. British Society for Medical Mycology. Eur. J. Clin. Microbiol. Infect. Dis. 1997;16(6): 424-436.
  2. Singh N., Gayowski T., Wagener M.M. et al. Invasive fungal infections in renal transplant recipients receiving tacrolimus as the primary immunosuppressive agent. Clin. Infect. Dis. 1997;24: 179-185.
  3. Odds F.C. Treatment of invasive fungal diseas: will combination antifungal therapy reduce martality? 13-th European Congress of Clinical Microbiology and Infectious Diseases May 10-13, 2003, Glasgow, UK
  4. Altiparmak M.R., Apaydin S., Trablus S. Systemic fungal infections after renal transplantation. Scand. J. Infect. Dis. 2002; 34(4): 284-288.
  5. Hibberd P.L., Rubin R.H. Clinical aspects of fungal infection in organ transplant recipients. Clin. Infect. Dis.-1994; 19 (Suppl. 1): S.33-40.
  6. Wu G., Vilchez R.A., Eidelman B. et al. Cryptococcal meningitis: an analysis among 5,521 consecutive organ transplant recipients. Transpl. Infect Dis. 2002; 4(4): 183-188.
  7. Colomba C., Antinori S. Fungal infections in transplantation patients. Recenti Prog. Med. 2003;94(11): 516-528.
  8. Echo A., Hovsepian R.V., Shen G.K. Localized cecal zygomycosis following renal transplantation. Transpl. Infect. Dis. 2005; 7(2): 68-70.
  9. Nampoory M.R., Khan Z.U., Johny K.V. et al. Nocardiosis in renal transplant recipients in Kuwait. Nephrol. Dial. Transplant. 1996; 11(6): 1134-1138.
  10. John G.H., Shankar V., Talaulicar G. et al. Epidemiology of systemic mycoses among renal-transplant recipients in India. Transplantation. 2003; 75: 1544-1551.
  11. Gabriel M. Danovitch. Handbook of Kidney Transplantation. Lippincott Williams@ Wilkins. 2004. P.471.
  12. van Hal S.J., Marriott D.J., Chen S.C. et al. Candidemia following solid organ transplantation in the era of antigungal prophilaxis: the Australian axperience. Transpl Infect Dis. 2009;11:122-127.
  13. Carol A. Kauffman., Gerald L. Mandell. Atlas of fungal infection. Springer. 2010:233.
  14. Dianne B. McKay, Steven M. Steinberg. Kidney Transplantation: A Guide to the Care of Kidney Transplant Recipients. Springer. 2010:407.

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML
Baixar

Declaração de direitos autorais © Bionika Media, 2012

Este site utiliza cookies

Ao continuar usando nosso site, você concorda com o procedimento de cookies que mantêm o site funcionando normalmente.

Informação sobre cookies